Home  »  Industry   »  EW’s Financial Health: Exploring Edwards Lif...

EW’s Financial Health: Exploring Edwards Lifesciences Corporation’s Debt-to-Equity Ratio of 1.79

Edwards Lifesciences Corporation (EW) currently has a stock price of $81.53. The stock saw a sharp increase in the last trading session, hitting a high of $84.44 after opening at $84.23. The lowest recorded price for the day was $83.58 before it closed at $83.84.

Edwards Lifesciences Corporation’s stock market performance has been somewhat irregular. The 1-year high for the company’s stock was recorded at $107.92 on 07/28/22, with the lowest value being $67.13 on 11/08/22.

Top 5 EV Tech Stocks to Buy for 2023

According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.

Click Here to Download the FREE Report.


52-week price history of EW Stock

Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Edwards Lifesciences Corporation’s current trading price is -24.45% away from its 52-week high, while its distance from the 52-week low is 21.45%. The stock’s price range for this period has remained between $67.13 and $107.92. The Healthcare sector company’s shares managed to surpass a trading volume of around 1.25 million for the day, which was noticeably lower compared to the shares’ average daily volume of 3.04 million over the last three months.

Financial Performance and Market Capitalization

Edwards Lifesciences Corporation (EW) has experienced a quarterly rise of 6.92% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 50.52B and boasts a workforce of 17300 employees.

Analysts’ Ratings For Edwards Lifesciences Corporation

As of right now, 13 analysts are rating Edwards Lifesciences Corporation as a BUY, 2 of the polled analysts branded the stock as an OVERWEIGHT, 14 analysts are recommending to HOLD this stock, 1 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.

Moving average and trading volume data

Based on Barchart.com data, the company’s moving average over the 100-day period was 81.54, with a change in price of +7.24. Similarly, Edwards Lifesciences Corporation recorded 3,163,378 in trading volume during the last 100 days, posting a change of +9.70%.

EW Debt-to-equity ratio analysis

The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for EW stands at 0.10. Similarly, the long-term debt-to-equity ratio is also 0.10.

EW Stock Stochastic Average

As of today, the raw stochastic average of Edwards Lifesciences Corporation over the past 50 days is 29.48%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 5.97%. Additionally, the Stochastic %K and %D values for the company were 14.79% and 40.59%, respectively, over the past 20 days.

EW Stock Price Performance Analysis

The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. Year to date metric has recorded a gain of 9.27%.However, over the last six months, we can see a weaker performance of 9.72%. Over the last 30 days, the price of EW has leaped by -6.73%. And in the last five days, it has fallen by -6.73%.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts